Yoga for Abdominal Obesity

Obesity, Abdominal Clinical Trial

Official title:

Randomized-controlled Trial of Yoga for Women With Abdominal Obesity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02420145
• Other study ID #: 15-6194-BO
• Status: Completed
• Phase: N/A
• First received: April 9, 2015
• Last updated: September 22, 2015
• Start date: April 2015
• Est. completion date: August 2015

Study information

• Verified date: September 2015
• Source: Universität Duisburg-Essen
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The aim of this randomized trial is to investigate the effects of a 12-week yoga intervention compared to no specific intervention on weight-related outcomes, well-being, and health behaviour in 60 females with abdominal obesity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: August 2015
• Est. primary completion date: August 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Waist circumference at least 88cm

• Body mass index at least 25

• Sedentary

• Physical and mental ability to participate in the yoga intervention

• Willingness to participate in at least 18 of 24 yoga sessions and the whole-day workshop

Exclusion Criteria:

• Dementia

• Psychosis

• Severe hypertension (diastolic blood pressure more than 120mmHg)

• Type 1 diabetes or insulin-dependent 2 diabetes

• Coronary artery disease

• Myocardial infarction

• Lung embolism

• Stroke

• Regular physical activity or yoga practice

• Pregnancy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Obesity
• Obesity, Abdominal

Intervention

Behavioral:
• Yoga
12 weeks of yoga, twice weekly for 90 minutes plus a whole-day workshop

Locations

Country	Name	City	State
Germany	Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen	Essen

Sponsors (1)

Lead Sponsor	Collaborator
Universität Duisburg-Essen

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Waist circumference		Week 12	No
Secondary	BMI	Body Mass Index	Week 12	No
Secondary	Body weight		Week 12	No
Secondary	Quality of life	36-Item Short Form Health Survey (SF-36)	Week 12	No
Secondary	Self esteem	Self-Esteem Scale (SES):	Week 12	No
Secondary	Body awareness	Body Awareness Questionnaire (BAQ)	Week 12	No
Secondary	Body responsiveness	Body Responsiveness Scale (BRS)	Week 12	No
Secondary	Perceived stress	Cohen's Perceived Stress Scale (PSS):	Week 12	No
Secondary	Health-specific self-efficacy	Health-Specific Self-Efficacy Scale	Week 12	No
Secondary	Fruits and vegetables consumption	Five A Day Food Frequency Questionnaire (FADFFQ)	Week 12	No
Secondary	Physical activity	The Questionnaire of Baecke et al. for the Measurement of a Person´s Habitual Physical Activity	Week 12	No
Secondary	Adherence	Class attendance and home practice (log)	Week 12	No
Secondary	Adverse events	Safety will be assessed as adverse events and serious adverse events	Week 12	Yes
Secondary	Qualitative interview	Qualitative interview on experiences and perceived changes	Week 12	No
Secondary	Waist-hip ratio		Week 12	No
Secondary	Bioelectrical impedance analysis		Week 12	No
Secondary	Systolic blood pressure		Week 12	No
Secondary	Diastolic blood pressure		Week 12	No